Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Proteomics International Laboratories Ltd. ( (AU:PIQ) ) has shared an announcement.
Proteomics International Laboratories Ltd has announced the appointment of Vicki Robinson as a new director, effective from October 14, 2025. The initial director’s interest notice indicates that Robinson currently holds no securities in the company, which suggests a neutral impact on the company’s stock ownership structure. This appointment could potentially influence the company’s strategic direction, given Robinson’s role on the board.
The most recent analyst rating on (AU:PIQ) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Proteomics International Laboratories Ltd. stock, see the AU:PIQ Stock Forecast page.
More about Proteomics International Laboratories Ltd.
Proteomics International Laboratories Ltd operates in the biotechnology industry, focusing on the development of diagnostic tests and analytical services. The company is known for its work in proteomics, which involves the large-scale study of proteins, particularly their structures and functions.
Average Trading Volume: 348,741
Technical Sentiment Signal: Sell
Current Market Cap: A$61.38M
For a thorough assessment of PIQ stock, go to TipRanks’ Stock Analysis page.